Boundless Bio, Inc. (NASDAQ: BOLD) is a Healthcare company (Biotechnology) with a market capitalization of $57M. The Maz Rating grades it against the other companies in its sector.
Boundless Bio, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $2.41, Boundless Bio, Inc. trades at 0.9x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -71.0%, return on invested capital of -95.7% and a free cash flow yield of -100.5%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 33.97. Over the past 52 weeks the share price ranged from $0.96 to $3.16, with a beta of 0.38.
Boundless Bio, Inc. does not currently pay a dividend.
20 Wall Street analyst ratings cover the stock: 6 Buy, 13 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.